Prospect Financial Services LLC Acurx Pharmaceuticals, Inc. Call Options Transaction History
Prospect Financial Services LLC
- $180 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACXP
# of Institutions
30Shares Held
3.55MCall Options Held
100Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ2.04MShares$838,2636.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA529KShares$217,0330.0% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$70,3090.0% of portfolio
-
Morgan Stanley New York, NY106KShares$43,5420.0% of portfolio
-
Vanguard Capital Wealth Advisors46KShares$18,8600.02% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $4.74M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...